Unlimited application potential.
Specialized for engineering applications.
Over 280 materials to choose from.
From polymers to composites to metals.
Optimize production processes
Keeping defense assets operational
A 3D Printer Platform Made for Education
Take your designs to the next level
Explore our support content
Pricing or financing options
Press and general inquiries
Contact our support team directly
Furthering Ultimaker's dedication to reliability and accessibility, we're excited to announce that the Ultimaker S5 has been certified by Materialise as a 3D printing solution to create orthopedic, maxillofacial, and cardiovascular models for clinical use when used in combination with Mimics inPrint software. The company partnered with Materialise to identify compatibility of the Ultimaker S5 with Materialise Mimics inPrint software to meet FDA regulatory guidelines for point-of-care 3D printing in hospitals.
While a growing number of free and commercial medical imaging software is available, in some cases within the United States, models marketed for diagnostic use must be prepared using software cleared by the FDA, such as Materialise Mimics inPrint.
Dedicated to fostering secure, accessible, and reliable 3D printing environments in the world of patient care, Materialise was a natural choice to bolster Ultimaker's offerings. “This solution we’ve developed with Ultimaker will improve access to 3D printed anatomical models to aid in surgical planning and multidisciplinary team communication,” explains Bryan Crutchfield, vice president and general manager of Materialise North America. The large build volume of the Ultimaker S5 allows for true-to-size models that open new doors for patient care and communication.
With the continued adoption of 3D printing for treatment planning and diagnostics, hospitals are recognizing that tangible, anatomically correct models make it easier to diagnose patients, plan surgeries, and discuss treatment where they would otherwise need to rely on 2D images. “The Materialise certification of the 3D printing workflow when used with Mimics inPrint reduces the safety and quality-control burden on doctors and hospitals with its clearance by the FDA,” says John Kawola, President of Ultimaker North America.
As 3D printing continues to change the face of diagnostics and care in the medical space, Ultimaker is proud to offer an affordable, steadfast option for hospitals that create 3D models from 2D scans. The partnership between Materialise and Ultimaker only enhances research flexibility and clinician communication, with reliability that reduces the strains of quality control and reduces the barrier to access for new technologies.
If you're interested in learning more, read the report below. You can also visit Ultimaker and Materialise at the upcoming RSNA 2018 Annual Meeting November 25th through November 30th in Chicago!
